World's Best Scientists 2026 revealed!
Award Badge
Medicine
New Zealand
2026

D-Index & Metrics

Medicine

D-Index
115
Citations
83172
World Ranking
4425
National Ranking
9

Research.com Recognitions

  • 2026 - Research.com Medicine in New Zealand Leader Award
  • 2025 - Research.com Medicine in New Zealand Leader Award

Overview

Edward Gane is affiliated with Auckland City Hospital in New Zealand and has a research focus primarily in the field of Medicine, with significant contributions to subfields such as Epidemiology, Hepatology, Oncology, Infectious Diseases, and Immunology.

Their work extensively covers topics related to hepatitis viruses, liver diseases, and cancer immunotherapy. Specifically, their main topics of research include:

  • Hepatitis B Virus Studies
  • Hepatitis C virus research
  • Liver Disease Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Cancer Immunotherapy and Biomarkers
  • Hepatitis Viruses Studies and Epidemiology
  • Immunotherapy and Immune Responses

Edward Gane has authored multiple papers, some recent examples include:

  • Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study, 2022, The 'Lancet. Gastroenterology & hepatology
  • Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study, 2020, The Lancet Oncology
  • Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy, 2020, Clinical Microbiology Reviews
  • Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial, 2022, The Lancet Oncology
  • Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial, 2020, Hepatology

Frequent co-authors working with Edward Gane include:

  • Man-Fung Yuen
  • Kosh Agarwal
  • Young-Suk Lim
  • Christian Schwabe
  • María Buti

Their publications often appear in specialized venues related to liver diseases and oncology, with notable frequent publication platforms such as:

  • Journal of Hepatology
  • Hepatology
  • The 'Lancet. Gastroenterology & hepatology
  • Journal of Clinical Oncology
  • Alimentary Pharmacology & Therapeutics

Best Publications

  • Sorafenib in Advanced Hepatocellular Carcinoma

    Josep M. Llovet;Sergio Ricci;Vincenzo Mazzaferro;Philip Hilgard

  • Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

    S. K. Sarin;M. Kumar;G. K. Lau;Z. Abbas

  • Sofosbuvir for previously untreated chronic hepatitis C infection

    Eric Lawitz;Alessandra Mangia;David Wyles;Maribel Rodriguez-Torres

  • Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

    Sarah Blach;Stefan Zeuzem;Michael Manns;Ibrahim Altraif

  • Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

    Patrick Marcellin;Edward J Gane;Maria Buti;Nezam H Afdhal

  • Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B

    George K.K. Lau;Teerha Piratvisuth;Kang Xian Luo;Patrick Marcellin

  • Peginterferon alfa-2a in patients with chronic hepatitis C.

    S Zeuzem;S V Feinman;J Rasenack;E J Heathcote

  • Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update

    Yun-Fan Liaw;Nancy H. L. Leung;Jia-Horng Kao;Teerha Piratvisuth

  • Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B

    Patrick Marcellin;E Jenny Heathcote;Maria Buti;Ed Gane

  • Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update.

    Yun Fan Liaw;Jia Horng Kao;Teerha Piratvisuth;Henry Lik Yuen Chan

  • Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis

    Merrill D. Benson;Márcia Waddington-Cruz;John L. Berk;Michael Polydefkis

  • Telbivudine versus lamivudine in patients with chronic hepatitis B.

    Ching-Lung Lai;Edward Gane;Yun-Fan Liaw;Chao-Wei Hsu

  • Long-Term Outcome of Hepatitis C Infection after Liver Transplantation

    Edward J. Gane;Bernard C. Portmann;Nikolai V. Naoumov;Heather M. Smith

  • Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

    Graham R. Foster;Nezam Afdhal;Stuart K. Roberts;Norbert Bräu

  • Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C

    Edward J. Gane;Catherine A. Stedman;Robert H. Hyland;Xiao Ding

  • 2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B

    Yun–Fan Liaw;Edward Gane;Nancy Leung;Stefan Zeuzem

  • Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B

    E. Jenny Heathcote;Patrick Marcellin;Maria Buti;Edward Gane

  • Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update.

    Yun-Fan Liaw;Nancy Leung;Richard Guan;George K.K. Lau

  • Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

    Michael Manns;Didier Samuel;Edward J Gane;David Mutimer

  • Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers

    Alexander J.V. Thompson;Tin Nguyen;David Iser;David Iser;Anna Ayres

Frequent Co-Authors

John G. McHutchison
John G. McHutchison Duke University
Stefan Zeuzem
Stefan Zeuzem Goethe University Frankfurt
Eric Lawitz
Eric Lawitz The University of Texas at Austin
Maria Buti
Maria Buti Instituto de Salud Carlos III
Patrick Marcellin
Patrick Marcellin Université Paris Cité
Ira M. Jacobson
Ira M. Jacobson New York University
Alexander J. Thompson
Alexander J. Thompson Ascension Health
Gregory J. Dore
Gregory J. Dore University of New South Wales
Gail V. Matthews
Gail V. Matthews University of New South Wales
Peter W Angus
Peter W Angus Austin Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens up numerous online degree and career paths in healthcare. Advanced nursing roles, for example, are increasingly accessible through flexible online programs tailored for busy professionals and career changers.

If you’re looking to specialize further after becoming a nurse, consider enrolling in a shortest post master's dnp program. These programs help experienced nurses advance quickly to leadership or academic roles.

For those seeking a less traditional pathway, there are also dnp program without clinical hours available. These options can make it easier to balance studies with existing work or life commitments.

Newcomers to nursing can benefit from a lpn program, which provides a fast-track route into the healthcare workforce with practical training.

Additionally, mental health professionals can advance their expertise with specialized online programs, such as the online msn pmhnp programs, designed for those passionate about psychiatric and mental health care.

Best Scientists Citing Edward Gane

Trending Scientists

Recently Published Articles